Zobrazeno 1 - 10
of 84
pro vyhledávání: '"María Butí"'
Autor:
Camila A. Picchio, Sabela Lens, Manuel Hernandez-Guerra, Juan Arenas, Raúl J. Andrade, Javier Crespo, Javier García-Samaniego, Manuel Romero-Gómez, Juan Turnes, José Luis Calleja, Miguel Ángel Simón, Trenton M. White, Mar Riveiro-Barciela, Anna Pocurull, Dalia Morales-Arraez, Alexandra Gómez, Maria Buti, Jeffrey V. Lazarus
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Chronic viral hepatitis infection affects an estimated 325 million people globally. People who initiate treatment after significant disease progression face increased risk of severe liver complications and death. Data are scarce on the chara
Externí odkaz:
https://doaj.org/article/d262e6bd25e842b3a55ada02b9f2ae1b
Autor:
Camila A. Picchio, Daniel K. Nomah, Silvia G. Araujo, Ariadna Rando-Segura, Emma Fernández, Maria Buti, Sergio Rodríguez-Tajes, Sabela Lens, Francisco Rodríguez-Frías, Jeffrey V. Lazarus
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Chronic hepatitis B virus (HBV) infection is a major public health threat for migrant populations in Spain and efforts to scale up testing are needed to reach the WHO elimination targets. The Hepatitis B Virus Community Screening and Vaccina
Externí odkaz:
https://doaj.org/article/63725d6b02b54e2bb89555e1f1c39fb9
Autor:
Laia Aceituno, Juan Bañares, Lourdes Ruiz-Ortega, Ana Callejo-Pérez, Eva Muñoz-Couselo, Carolina Ortiz-Velez, Nely Díaz-Mejía, Ana Barreira-Díaz, María José Carreras, Anna Farriols, María Buti, Mar Riveiro-Barciela
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Background and AimsImmunotherapy with immune checkpoint inhibitors (ICIs) is a pillar of many advanced tumors. However, there is scarce data concerning the rate of viral hepatitis screening in this population or the risk of viral reactivation.Methods
Externí odkaz:
https://doaj.org/article/8adbd67a6ece4095ba87e2b28faf0461
Autor:
Maria Francesca Cortese, Mar Riveiro-Barciela, David Tabernero, Francisco Rodriguez-Algarra, Adriana Palom, Sara Sopena, Ariadna Rando-Segura, Luisa Roade, Alison Kuchta, Roser Ferrer-Costa, Josep Quer, Beatriz Pacin, Marta Vila, Rosario Casillas, Selene Garcia-Garcia, Rafael Esteban, Tomás Pumarola, Maria Buti, Francisco Rodriguez-Frias
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 2 (2022)
ABSTRACT The measurement and interpretation of HBV DNA and RNA levels in HBV infected patients treated with antiviral therapy supports the objective of HBV disease management. Here, we quantified circulating HBV RNA through a standardized and sensiti
Externí odkaz:
https://doaj.org/article/df42fb28fa3d42c3938318d35d4f8b52
Autor:
Maria Francesca Cortese, Carolina González, Josep Gregori, Rosario Casillas, Luca Carioti, Mercedes Guerrero-Murillo, Mar Riveiro-Barciela, Cristina Godoy, Sara Sopena, Marçal Yll, Josep Quer, Ariadna Rando, Rosa Lopez-Martinez, Beatriz Pacín Ruiz, Selene García-García, Rafael Esteban-Mur, David Tabernero, Maria Buti, Francisco Rodríguez-Frías
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Patients with HBeAg-negative chronic infection (CI) have not been extensively studied because of low viremia. The HBx protein, encoded by HBX, has a key role in viral replication. Here, we analyzed the viral quasispecies at the 5′ end of H
Externí odkaz:
https://doaj.org/article/8bae6b63e6994cb78433411466be5879
Autor:
Maria Butiu, Bogdan Obrisca, MD, Lena Sibulesky, MD, Ramasamy Bakthavatsalam, MD, Kelly D. Smith, MD, Idoia Gimferrer, MD, PhD, Paul Warner, PhD, Gener Ismail, MD, Nicolae Leca, MD
Publikováno v:
Transplantation Direct, Vol 8, Iss 2, p e1285 (2022)
Background. We sought to evaluate the association between de novo donor-specific antibodies (dnDSAs) class and their mean fluorescence intensity (MFI) with donor-derived cell-free DNA (dd-cfDNA), aiming to further clarify the biomarker utility of the
Externí odkaz:
https://doaj.org/article/9ee89d85abed49e4b209f988d283a291
Autor:
Jeffrey V Lazarus, Juan Manuel Alonso, Camila A Picchio, Maria Buti, Andrea Herranz, Marcela Villota-Rivas, Antonia Rodríguez, Albert Moratinos, Antonella Perrotta, Elisabet Tegeo, Francisca Bibiloni, Àngels Vilella
Publikováno v:
BMJ Open, Vol 11, Iss 10 (2021)
Externí odkaz:
https://doaj.org/article/74eb3004060a43cca0fe2e6178092bf8
Autor:
Lara Grau-López, Cristina Marcos-Fosch, Constanza Daigre, Raúl Felipe Palma-Alvarez, Ariadna Rando-Segura, Jordi Llaneras, Marta Perea-Ortueta, Francisco Rodriguez-Frias, Nieves Martínez-Luna, Mar Riveiro-Barciela, Josep Antoni Ramos-Quiroga, Joan Colom, Rafael Esteban, María Buti
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Background: Hepatitis C virus (HCV) management is a challenge in patients with substance use disorder (SUD). This study aimed to describe an HCV screening and linkage to care program in SUD patients, and analyze the characteristics of this population
Externí odkaz:
https://doaj.org/article/ef43e1ce8b5c4d57abebc3214ced198c
Autor:
Maria Buti, Maria Stepanova, Adriana Palom, Mar Riveiro-Barciela, Fatema Nader, Luisa Roade, Rafael Esteban, Zobair Younossi
Publikováno v:
JHEP Reports, Vol 3, Iss 3, Pp 100280- (2021)
Background & Aims: Health-related quality of life (HRQoL) determined by patient-reported outcomes (PROs) is impaired in chronic hepatitis B (CHB) and C patients, but there are no data regarding patients with chronic hepatitis D (CHD). The aim of this
Externí odkaz:
https://doaj.org/article/c5867719915c497d8b09d0bcbd1830da
Autor:
George V. Papatheodoridis, George N. Dalekos, Ramazan Idilman, Vana Sypsa, Florian Van Boemmel, Maria Buti, Jose Luis Calleja, John Goulis, Spilios Manolakopoulos, Alessandro Loglio, Margarita Papatheodoridi, Nikolaos Gatselis, Rhea Veelken, Marta Lopez-Gomez, Bettina E. Hansen, Savvoula Savvidou, Anastasia Kourikou, John Vlachogiannakos, Kostas Galanis, Cihan Yurdaydin, Rafael Esteban, Harry L.A. Janssen, Thomas Berg, Pietro Lampertico
Publikováno v:
JHEP Reports, Vol 3, Iss 3, Pp 100290- (2021)
Background & Aims: Recently, several risk scores for prediction of hepatocellular carcinoma (HCC) were developed in cohorts of treated Asian patients with chronic hepatitis B (CHB), but they have not been assessed in non-Asian patients. We evaluated
Externí odkaz:
https://doaj.org/article/d08615186346466785283c3570703c61